Related references
Note: Only part of the references are listed.TolC, but not AcrB, is involved in the invasiveness of multidrug-resistant Salmonella enterica serovar Typhimurium by increasing type III secretion system-1 expression
Isabelle Virlogeux-Payant et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
KmrA multidrug efflux pump from Klebsiella pneumoniae
W Ogawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Antibiotic-sensitive TolC mutants and their suppressors
AM Augustus et al.
JOURNAL OF BACTERIOLOGY (2004)
AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex
EB Tikhonova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structure andfunction of tolC: The bacterial exit duct for proteins and drugs
V Koronakis et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
ModLoop: automated modeling of loops in protein structures
A Fiser et al.
BIOINFORMATICS (2003)
Structure and function of efflux pumps that confer resistance to drugs
MI Borges-Walmsley et al.
BIOCHEMICAL JOURNAL (2003)
TolC - the bacterial exit duct for proteins and drugs
V Koronakis
FEBS LETTERS (2003)
Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore
T Schneiders et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria
EB Tikhonova et al.
JOURNAL OF BACTERIOLOGY (2002)
AcrAB efflux system:: Expression and contribution to fluoroquinolone resistance in Klebsiella spp.
A Mazzariol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Role of the outer membrane in the accumulation of quinolones by Serratia marcescens
M Berlanga et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2000)
TolC, a macromolecular periplasmic 'chunnel'
K Postle et al.
NATURE STRUCTURAL BIOLOGY (2000)
A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus:: Evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux
R Beyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
